• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Dose response relationship of citalopram 20 mg, citalopram 40 mg and placebo in the treatment of moderate and severe depression.

作者信息

Montgomery S A, Rasmussen J G, Lyby K, Connor P, Tanghøj P

机构信息

St Mary's Hospital, Academic Department of Psychiatry, London, UK.

出版信息

Int Clin Psychopharmacol. 1992 Jun;6 Suppl 5:65-70. doi: 10.1097/00004850-199206005-00007.

DOI:10.1097/00004850-199206005-00007
PMID:1431024
Abstract
摘要

相似文献

1
Dose response relationship of citalopram 20 mg, citalopram 40 mg and placebo in the treatment of moderate and severe depression.
Int Clin Psychopharmacol. 1992 Jun;6 Suppl 5:65-70. doi: 10.1097/00004850-199206005-00007.
2
Citalopram 20 mg, citalopram 40 mg and placebo in the prevention of relapse of major depression.20毫克西酞普兰、40毫克西酞普兰及安慰剂用于预防重度抑郁症复发
Int Clin Psychopharmacol. 1992 Jun;6 Suppl 5:71-3. doi: 10.1097/00004850-199206005-00008.
3
Citalopram in depression--meta-analysis of intended and unintended effects.西酞普兰治疗抑郁症——预期和非预期效应的荟萃分析
Int Clin Psychopharmacol. 1992 Jun;6 Suppl 5:45-54. doi: 10.1097/00004850-199206005-00005.
4
The optimal dosing regimen for citalopram--a meta-analysis of nine placebo-controlled studies.西酞普兰的最佳给药方案——九项安慰剂对照研究的荟萃分析。
Int Clin Psychopharmacol. 1994 Mar;9 Suppl 1:35-40. doi: 10.1097/00004850-199403001-00006.
5
Citalopram and imipramine in the treatment of depressive patients in general practice. A Nordic multicentre clinical study.
Int Clin Psychopharmacol. 1994 Mar;9 Suppl 1:41-8. doi: 10.1097/00004850-199403001-00007.
6
Citalopram in doses of 20-60 mg is effective in depression relapse prevention: a placebo-controlled 6 month study.
Int Clin Psychopharmacol. 1995 Mar;10 Suppl 1:29-35.
7
Citalopram dose-response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depression.使用另一种心理测量方法重新审视西酞普兰的剂量反应，以评估与安慰剂相比，四种固定剂量西酞普兰对重度抑郁症患者的临床疗效。
Psychopharmacology (Berl). 2002 Aug;163(1):20-5. doi: 10.1007/s00213-002-1147-6. Epub 2002 Jul 3.
8
Effective dose of escitalopram in moderate versus severe DSM-IV major depression.艾司西酞普兰治疗中度与重度DSM-IV重度抑郁症的有效剂量。
Pharmacopsychiatry. 2006 Jul;39(4):128-34. doi: 10.1055/s-2006-946702.
9
Escitalopram continuation treatment prevents relapse of depressive episodes.艾司西酞普兰持续治疗可预防抑郁发作的复发。
J Clin Psychiatry. 2004 Jan;65(1):44-9. doi: 10.4088/jcp.v65n0107.
10
Citalopram versus nortriptyline in late-life depression: a 12-week randomized single-blind study.
Acta Psychiatr Scand. 2001 Jun;103(6):435-40. doi: 10.1034/j.1600-0447.2001.00228.x.

引用本文的文献

1
Control Group Outcomes in Trials of Psilocybin, SSRIs, or Esketamine for Depression: A Meta-Analysis.裸盖菇素、选择性5-羟色胺再摄取抑制剂（SSRI）或艾司氯胺酮治疗抑郁症试验中的对照组结果：一项荟萃分析。
JAMA Netw Open. 2025 Jul 1;8(7):e2524119. doi: 10.1001/jamanetworkopen.2025.24119.
2
Safer citalopram use in primary care: Can staff education and prescribing prompts improve adherence to national guidance? A closed loop clinical audit, service evaluation and quality improvement study.在初级保健中更安全地使用西酞普兰：员工教育和处方提示能否提高对国家指南的依从性？一项闭环临床审计、服务评估和质量改进研究。
J Family Med Prim Care. 2022 Nov;11(11):7085-7088. doi: 10.4103/jfmpc.jfmpc_772_22. Epub 2022 Dec 16.
3
Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis.
选择性5-羟色胺再摄取抑制剂与安慰剂治疗重度抑郁症患者的比较：一项Meta分析及序贯试验分析的系统评价
BMC Psychiatry. 2017 Feb 8;17(1):58. doi: 10.1186/s12888-016-1173-2.
4
Citalopram for major depressive disorder in adults: a systematic review and meta-analysis of published placebo-controlled trials.西酞普兰治疗成人重性抑郁障碍：已发表安慰剂对照试验的系统评价和荟萃分析。
BMJ Open. 2011 Jan 1;1(2):e000106. doi: 10.1136/bmjopen-2011-000106.
5
Blue again: perturbational effects of antidepressants suggest monoaminergic homeostasis in major depression.再次呈现蓝色：抗抑郁药的扰动效应表明重性抑郁症中单胺能稳态。
Front Psychol. 2011 Jul 7;2:159. doi: 10.3389/fpsyg.2011.00159. eCollection 2011.
6
Differential effects of venlafaxine in the treatment of major depressive disorder according to baseline severity.根据基线严重程度，文拉法辛治疗重度抑郁症的差异效应。
Eur Arch Psychiatry Clin Neurosci. 2009 Sep;259(6):329-39. doi: 10.1007/s00406-009-0003-7. Epub 2009 Mar 3.
7
Dose-response relationship of recent antidepressants in the short-term treatment of depression.近期抗抑郁药在抑郁症短期治疗中的剂量-反应关系。
Dialogues Clin Neurosci. 2005;7(3):249-62. doi: 10.31887/DCNS.2005.7.3/pberney.
8
Is dose escalation of antidepressants a rational strategy after a medium-dose treatment has failed? A systematic review.中等剂量治疗失败后增加抗抑郁药剂量是否为合理策略？一项系统评价。
Eur Arch Psychiatry Clin Neurosci. 2005 Dec;255(6):387-400. doi: 10.1007/s00406-005-0579-5. Epub 2005 Apr 29.
9
Evidence b(i)ased medicine--selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications.循证医学——制药行业赞助研究的选择性报告：新药申请研究综述
BMJ. 2003 May 31;326(7400):1171-3. doi: 10.1136/bmj.326.7400.1171.
10
Citalopram--a review of pharmacological and clinical effects.西酞普兰——药理作用与临床效果综述
J Psychiatry Neurosci. 2000 May;25(3):241-54.